| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |